Longeveron Partners with Kinesiometrics to Create and Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell Therapy

NEXT STORY
TG Therapeutics Recaps Schedule of Upcoming Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
PREV STORY
Dr. Henry Ji, Sorrento Chairman and CEO, to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Axsome Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Zai Lab Limited Announces Pricing of U.S. Initial Public Offering of ADSs

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces ...

author_avatar
NASDAQ Market News

Chiesi Group receives European Marketing Authorization for Trimbow® inhalation powder (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium) delivered through NEXThaler, an extrafine formulation fixed triple combination therapy for the treatment of moderate to severe COPD

author_avatar
NASDAQ Market News